NCT06599398

Brief Summary

The goal of this observational study is to evaluate an innovative pediatric transitional care unit called the Jeroen Pit Huis (JPH). The primary objective of our study is to investigate whether an intermediate stay between hospital and home in the JPH have a favourable effect on healthcare consumption, patient, parent and family-relevant quantitative outcome measures, compared to discharge directly from a hospital ward. Parents will be asked to complete several questionnaires on three different time points (at discharge, 3 and 12 months of follow up).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
0mo left

Started Dec 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Dec 2023Jun 2026

First Submitted

Initial submission to the registry

September 15, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
10 months until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

1.5 years

First QC Date

September 15, 2023

Last Update Submit

September 13, 2024

Conditions

Keywords

Children with Medical Complexity

Outcome Measures

Primary Outcomes (1)

  • Parental distress

    Distress Thermometer for Parents (DT-P)

    Baseline, 3 and 12 months of follow-up

Secondary Outcomes (15)

  • Quality of Life of children

    Baseline, 3 and 12 months of follow-up

  • Growth weight parameters

    Study inclusion, baseline, 3 and 12 months of follow-up

  • Growth length parameters

    Study inclusion, baseline, 3 and 12 months of follow-up

  • Impact of having a CMC on parents' Quality of Life and family functioning

    Baseline, 3 and 12 months of follow-up

  • Impact on parental employment

    12 months of follow-up

  • +10 more secondary outcomes

Study Arms (2)

Intervention group

The intervention group comprise patients and families who had an intermediate stay between hospital and home in the Jeroen Pit Huis (JPH)

Other: Jeroen Pit Huis

Control groups

The control groups comprise patients and families who undergo the hospital to home transition directly from the hospital. This includes patients from the EMC, RUMC, and UMCG. Patients from the AUMC who transition directly from hospital to home without an intermediate stay in the JPH will also be included in the control group.

Other: Jeroen Pit Huis

Interventions

The JPH is a unique and innovative Transitional Care Unit (TCU) situated in close proximity of the AUMC. In this TCU, patients and their family reside in separate private home-like apartments. The families can stay while practising in, and adapting to, their new reality until they are ready to transition home. A multidisciplinary team of healthcare experts (nurses, psychosocial care workers, family counsellors, and paediatricians) are gradually guiding parents towards taking on the role of their child's primary caregiver. This process is guided by a newly developed seven phase care path.One condition for staying in the JPH is that one parent is always present. In this form (24/7 parental stay and nursing care directly available under the supervision of pediatricians) the JPH is unique in the Netherlands.

Control groupsIntervention group

Eligibility Criteria

Age0 Minutes - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

The population exists of all children admitted to one of the four UMCs. The population will be predominantly CMC. CMC have one or more chronic conditions, functional limitations, high family identified needs, and a high use of healthcare resources \[1\]. Eligible participants fulfil all inclusion and no exclusion criteria.

Subject eligibility (or inclusion) criteria for this are as follows: 1. Age: at term (older than 37 weeks corrected gestational age) and younger than 18 years 2. Admitted to the hospital with (a deterioration of) a chronic complex condition (CCC) \[30\] and/or (expected) continuous dependence on technology after discharge (see ad 2 below). 3. Expected need of specialized medical and/or allied health care after discharge 4. A stable medical condition and/or a set treatment regimen (see below ad 4) 5. Discharge home not yet possible due to organization-, care- or family circumstances (see below ad 5) 6. Have given informed consent (consenting process is described in chapter 11.2 recruitment and consent) Ad 2 chronic complex condition Fulfils criteria of a chronic complex condition (CCC) \[30\] and/or (expected) continuous dependence on technology after discharge. A complex chronic condition (CCC) is defined according to Feudtner et al. (1) as "any medical condition that can be reasonably expected to last at least 12 months (unless death intervenes) and to involve either several different organ systems or one organ system severely enough to require specialty pediatric care and probably some period of hospitalization in a tertiary care center." Verlaat et al., updated the CCC list based on expert opinion \[31\]. A table of diagnosis classified as CCC can be found in appendix 1. An unknown but suspected complex and chronic condition, such as a child born with multiple congenital anomalies but lacking a unifying diagnosis, will be included. Ad 4 stable medical condition The patient is defined as being in a stable medical condition if there is: 1. A patent, safe airway to remain in the home situation, whether or not by means of a trachea cannula 2. Adequate respiration, whether or not by means of (intermittent) support with oxygen, non-invasive ventilation or invasive ventilation via a trachea cannula 3. A neurologically stable condition that may include temporary neurological impairments (such as seizures) not interfering (potentially life-threatening) with other vital functions such as respiration or circulation 4. Drug treatment that can be given at home where (if applicable): a nasogastric, duodenal or jejunal tube and/or a percutaneous endoscopic gastrostomy (PEG) tube is in situ, or if necessary, a 'home-proof' intravenous access is guaranteed 5. In case of enteral tube feeding, the nasogastric, duodenal or jejunal tube and/or a percutaneous endoscopic gastrostomy (PEG) tube is in situ, and the feeding schedule may be built up, reduced or variable if there are no contraindications for this. In case of parenteral feeding, the parenteral nutrition home program must be organized according to the home situation. Ad 5 organization-, care- or family circumstances include the lack of 1 or more of the following requirements for safe discharge home: 1. A sustainable care plan using the four 'Medische Kindzorg Systeem' domains (medical, safety, development and social) has been drawn up that includes all four domains such as among others (Medical Child care System that is used in The Netherlands to structure medical child care in the home situation): * care needs * clear coordination of tasks and responsibilities of parents and healthcare professionals (primary, secondary and tertiary care). 2. The necessary medical and nursing care support (such as a feeding pump, adequate home care). 3. Parents know who to contact with questions about the organization of care (e.g. financial issues, wheelchair, municipality) 4. Essential medical technology is available at home and can be used for care. 5. Reimbursement of care at home is adequately arranged. 6. The house is located and furnished in such a way that the child can stay in it safely (accessibility for emergency services, telephone contact with parents, technical facilities) Parents/informal carers are adequately trained to take care of the child in the home situation, that means that they: 7. Master care in all areas (medical, nursing, technical, psychosocial) 8. Obtain declaration of care competencies, in particular: * assessment for somatic deterioration * acting in emergency situations (e.g. seeking help, resuscitation and if applicable: cannula dislocation, PEG probe problems, docking of a seizure) * realizing when to call for help and whom to call for help 9. Can obtain adequate telephone assistance (working telephone, English/Dutch speaking) 10. Are psychologically and emotionally ready to deal with new home situation (according to care professionals) A potential subject will be excluded from participation in this study if: 1. The patient is in need of end-of-life care 2. Existence of predominantly social/family issues without serious medical problems in the index child 3. Patient with behavioural/psychiatric problems necessitating other type of care 4. Patient requiring rehabilitation medical care 5. Patients who are not directly discharged home from the hospital (except for the JPH (e.g. via de Boeg, Villa Expert Care)) 6. Contagious disease that requires strict isolation

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Amsterdam University Medical Centre

Amsterdam, Netherlands

RECRUITING

Related Publications (1)

  • Haspels HN, Mikkers MC, Knoester H, Jansen NJG, Ahout IML, Maaskant JM, van de Riet L, Haverman L, Dulfer K, Haasnoot M, Alsem MW, de Hoog M, van Woensel JBM, Joosten KFM, van Karnebeek CD; Transitional Care Unit Consortium. Bridging hospital to home for children with medical complexity and their families: an observational prospective cohort study protocol to assess the effectiveness of an innovative transitional care unit in the Netherlands (BRIDGE study). BMJ Open. 2025 Apr 19;15(4):e093693. doi: 10.1136/bmjopen-2024-093693.

Central Study Contacts

Heleen N Haspels, Msc

CONTACT

Clara Van Karnebeek, Prof. Dr.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. dr.

Study Record Dates

First Submitted

September 15, 2023

First Posted

September 19, 2024

Study Start

December 1, 2023

Primary Completion

June 1, 2025

Study Completion (Estimated)

June 1, 2026

Last Updated

September 19, 2024

Record last verified: 2024-09

Locations